PT Kalbe Farma (KLBF) Tbk booked net profit of Rp2.07 trillion last year, grew 7.3% only from 2013, while sales revenues increased 8.5% to Rp17.4 trillion. The largest pharmaceutical player on Indonesia Stock Exchange (IDX) is now valued 8.8 x equity and traded with PE multiple 41.8 on 2014 earnings.To subscribe please click here
